Elevance Health (ELV) reported earnings 30 days ago. What's next for the stock?

Pharmacy benefit managers (PBMs) sit at the chokepoint of U.S. drug distribution.

On May 19, 2026, we present a detailed DCF analysis for Elevance Health Inc (ELV), a company currently trading at $394.07. The stock has shown a strong price pe

Elevance Health, Inc. (ELV) Shareholder/Analyst Call Prepared Remarks Transcript

On May 12, 2026, Elevance Health Inc (ELV) shares rose 4.0% today, bringing the current price to $393.30. The stock has experienced a 52-week range between $273

On May 12, 2026, we present a DCF analysis for Elevance Health Inc (ELV), a company currently trading at $381.75. The stock has shown mixed performance, with a

On May 08, 2026, we conducted a DCF analysis for Elevance Health Inc (ELV) to assess its intrinsic value in the context of its recent price performance. Over th

Solid first-quarter results from major insurers like UnitedHealth, Elevance, Cigna and Humana have helped lift investor sentiment, even as insurers continue to grapple with higher medical costs. But analysts caution that insurers have incomplete data on medical costs in the first quarter due to a lag in claims processing, which sets up the second quarter as the real proving ground.

Don Lair writes about options income, dividend strategy, and the kind of boring-but-durable investing that actually funds retirement.

INDIANAPOLIS--(BUSINESS WIRE)--Despite growing awareness, mental health concerns remain difficult to navigate and often lead to avoidable crises, costly emergency room visits, and long-term strain on individuals, families, and an already overburdened healthcare system. With nearly one in five Americans experiencing a diagnosable mental health condition each year, the need for funding and systemic improvement has never been greater. That's why Elevance Health is focused on addressing some of the.